Latest News Releases From The Newsroom
National Western Life Group Exploring Strategic Alternatives, Bausch Health Surges on U.S. District Court's Decision, Kura Oncology Initiated with a Buy
May 17th, 2023
National Western Life Group, Inc. (Nasdaq: NWLI) has announced its intention to explore strategic alternatives with the aim of maximizing value for its stockholders. At this stage, no specific decision has been made regarding a sale, merger, or other. Read more
Jack in the Box Beats Estimates, Expands Into New Markets; Remark Holdings Inks Strategic Partnership; AppLovin Upgraded
May 17th, 2023
Jack in the Box Inc. (Nasdaq: JACK) reported operating earnings per share of $1.47 for the second quarter of fiscal year 2023, surpassing the consensus estimate of $1.22 per share. Additionally, the company has made significant expansion announcem. Read more
Immutep's Eftilagimod Alpha Shows Promise in Phase II Trial, Lightning eMotors Reports Q1 Loss and $50M Pre-Paid Advance Deal, BioNTech Upgraded to Buy
May 17th, 2023
Immutep Limited (Nasdaq: IMMP) has received positive feedback from the US Food and Drug Administration (FDA) for its late-stage clinical development plans for Eftilagimod Alpha ("efti") in the treatment of 1st line non-small cell lung cancer. In addi. Read more
Eightco's Forever 8 Renews IMA with Mobi-hub, Tencent Music Entertainment and iQIYI Upgraded
May 17th, 2023
Eightco Holdings Inc. (Nasdaq: OCTO) made an announcement regarding its subsidiary, Forever 8. The company has successfully renewed and expanded its Inventory Management Agreement (IMA) with Mobi-hub Ltd., a prominent electronics distributor speciali. Read more
ServiceNow Announces Share Repurchase Program, Target Exceeds Q1 Earnings Estimates, Sunrise New Energy Reports Impressive Revenue Growth
May 17th, 2023
ServiceNow, Inc. (NYSE: NOW) made an important announcement regarding its financial strategy. The company's Board of Directors has approved the initiation of a share repurchase program, marking the first of its kind for ServiceNow. This new program a. Read more
SEC Charges 10 Microcap Companies with Securities Offering Registration Violations
May 16th, 2023
FOR IMMEDIATE RELEASE 2023-94 Washington D.C. / CRWE PRESS RELEASE / May 16, 2023 — The Securities and Exchange Commission today announced charges against 10 microcap companies for offering and selling securities in unregistered . Read more
Keysight Beats Expectations, Kyndryl Falls Short; Northrop Grumman Declares Dividend, EVgo Launches Public Offering
May 16th, 2023
Keysight Technologies, Inc. (NYSE: KEYS) has released its financial results for the second fiscal quarter ending April 30, 2022. The company reported earnings per share (EPS) of $2.12, surpassing the consensus estimate of $1.95. Following the posi. Read more
FTC Takes Legal Action to Halt Amgen's Acquisition of Horizon Therapeutics Amid Monopoly Concerns, Applied Digital Secures Major AI Customer, Etsy Faces Price Target Revision
May 16th, 2023
The Federal Trade Commission (FTC) has taken action to prevent the acquisition of Horizon Therapeutics plc (Nasdaq: HZNP) by the biopharmaceutical giant, Amgen Inc. (Nasdaq: AMGN). In its efforts to block the transaction, the FTC has filed a lawsuit . Read more
FTC Sues to Block Biopharmaceutical Giant Amgen from Acquisition That Would Entrench Monopoly Drugs Used to Treat Two Serious Illnesses
May 16th, 2023
The $27.8 billion acquisition of Horizon Therapeutics plc would enable Amgen Inc. to stifle competition for thyroid eye disease and chronic refractory gout treatments, the agency says LAS VEGAS, NV / CRWE PRESS RELEASE / May 16, 2023 - The F. Read more
Stratasys Reports Strong Q1 Earnings, MINISO Exceeds Expectations, Upgrades for Expedia and Royal Caribbean
May 16th, 2023
Stratasys Ltd. (Nasdaq: SSYS) has delivered positive adjusted earnings per share for the seventh consecutive quarter. In the first quarter of 2023, the company reported an EPS of $0.02, surpassing the consensus estimate of a loss of $0.06 per share. . Read more
Want To Find Some News?
News By Industries
Recent Posts
-
FDA Approves Nerve Scaffold for the Treatment of Sensory Nerve Discontinuity
December 04th, 2025December 02nd, 2025Earnings Countdown: Salesforce, Snowflake, and Guidewire Take Center Stage
November 30th, 2025Wall Street Eyes CrowdStrike, Marvell Technology, and GitLab as Earnings Near
November 30th, 2025Earnings Preview: Credo Technology, MongoDB, and Hafnia in Focus
November 30th, 2025
Member Login